SON Stock Recent News

SON LATEST HEADLINES

SON Stock News Image - businesswire.com

BOSTON--(BUSINESS WIRE)--Fairmarkit, a leading AI-powered autonomous sourcing solutions provider, today announced its expanded partnership with Sonoco, a global leader in high-value sustainable packaging, to streamline procurement operations across Latin America. After a successful partnership with their North America team, Sonoco has broadened their use of Fairmarkit's AI-driven sourcing and procurement technology to standardize procurement workflows, automate sourcing requests, and centralize.

businesswire.com 2025 Jan 07
SON Stock News Image - globenewswire.com

HARTSVILLE, S.C., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today announced senior leadership changes which became effective on January 3, 2025.

globenewswire.com 2025 Jan 06
SON Stock News Image - globenewswire.com

Sonnet to receive $1.0 million in upfront payment and up to an additional $1.0 million in milestone payments with a royalty in the low double digits on net sales, less certain expenses, in the India market

globenewswire.com 2024 Oct 09
SON Stock News Image - zacks.com

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com 2024 Sep 26
SON Stock News Image - globenewswire.com

SON-1010 is a targeted immune activation cancer therapy designed to turn ‘cold' tumors ‘hot' Topline safety data of SB101 Phase 1 study expected by Q4 2024 PRINCETON, NJ, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced the completion of enrollment and initiation of dosing in its Phase 1 SB101 clinical trial of SON-1010 (IL12-FHAB) in adult patients with advanced solid tumors.

globenewswire.com 2024 Sep 18
SON Stock News Image - globenewswire.com

HARTSVILLE, S.C., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today announced that it has priced an offering (the “Offering”) of senior unsecured notes in a combined aggregate principal amount of $1.8 billion (collectively, the “Notes”).

globenewswire.com 2024 Sep 17
SON Stock News Image - zacks.com

Investors interested in stocks from the Containers - Paper and Packaging sector have probably already heard of Sonoco (SON) and AptarGroup (ATR). But which of these two stocks is more attractive to value investors?

zacks.com 2024 Sep 10
SON Stock News Image - zacks.com

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

zacks.com 2024 Sep 10
SON Stock News Image - globenewswire.com

HARTSVILLE, S.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a global leader in high-value sustainable packaging, today announced that it has initiated a review of strategic alternatives for the Company's Thermoformed & Flexible Packaging (“TFP”) business, a part of the Company's Consumer Packaging segment.

globenewswire.com 2024 Sep 04
SON Stock News Image - globenewswire.com

Preclinical data has demonstrated the potential of SON-1210, the first albumin-binding bifunctional IL-12/IL-15 fusion protein, for solid tumor immunotherapy

globenewswire.com 2024 Aug 19
10 of 50